(Q45142565)
Statements
1 reference
Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860). (English)
1 reference
Tomoichiro Asano
1 reference
Yasushi Saito
1 reference
Masanobu Kawakami
1 reference
Nobuhiro Yamada
1 reference
Hisakuni Sekino
1 reference
Setsuo Hasegawa
1 reference
Fidarestat Clinical Pharmacology Study Group
1 reference
1 November 2004
1 reference
1 reference
18
1 reference
6
1 reference
336-342
1 reference
Identifiers
1 reference
1 reference